These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 35305720)
21. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates. Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308 [TBL] [Abstract][Full Text] [Related]
22. Update on Treatment of Clostridioides difficile Infection. Cho JM; Pardi DS; Khanna S Mayo Clin Proc; 2020 Apr; 95(4):758-769. PubMed ID: 32247350 [TBL] [Abstract][Full Text] [Related]
23. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea. Abad CLR; Safdar N Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444 [TBL] [Abstract][Full Text] [Related]
24. New treatment approaches for Bratkovič T; Zahirović A; Bizjak M; Rupnik M; Štrukelj B; Berlec A Gut Microbes; 2024; 16(1):2337312. PubMed ID: 38591915 [No Abstract] [Full Text] [Related]
25. Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy. Shirley DA; Tornel W; Warren CA; Moonah S Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37560802 [TBL] [Abstract][Full Text] [Related]
26. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy. Mehta SR; Yen EF Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650 [TBL] [Abstract][Full Text] [Related]
27. How to: prophylactic interventions for prevention of Clostridioides difficile infection. Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E; Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901 [TBL] [Abstract][Full Text] [Related]
28. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection. Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM mBio; 2020 Mar; 11(2):. PubMed ID: 32156806 [TBL] [Abstract][Full Text] [Related]
29. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil. Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474 [TBL] [Abstract][Full Text] [Related]
38. Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections. Dieterle MG; Rao K; Young VB Ann N Y Acad Sci; 2019 Jan; 1435(1):110-138. PubMed ID: 30238983 [TBL] [Abstract][Full Text] [Related]
39. Look What the Cat Dragged in! Recurrent Clostridioides difficile from a Household Cat. Garza MA; Thomas B; Saleh A; Nabbout L; Quigley EMM; Mathur N Am J Case Rep; 2023 Oct; 24():e940923. PubMed ID: 37885171 [TBL] [Abstract][Full Text] [Related]
40. Review article: The epidemiology and management of Clostridioides difficile infection-A clinical update. Clarke LM; Allegretti JR Aliment Pharmacol Ther; 2024 Jun; 59(11):1335-1349. PubMed ID: 38534216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]